Patient Guide: Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06964815
Status: NOT_YET_RECRUITING
Condition: Glioblastoma
Phase: NA

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Bologna, BO
  • • Meldola, FC
  • • Catania, Italia/Catania
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients - Join Clinical Trial NCTNCT06964815

How to Join This Clinical Trial - NCTNCT06964815

Learn how to participate in this NA trial studying an investigational therapy for Glioblastoma. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Glioblastoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Glioblastoma
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT06964815 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Bologna, BO 40139 - Italy

Status: Contact for availability

Clinical Research Site

Meldola, FC 47014 - Italy

Status: Contact for availability

Clinical Research Site

Catania, Italia/Catania 95123 - Italy

Status: Contact for availability

Clinical Research Site

Firenze, Italia/FI 50134 - Italy

Status: Contact for availability

Clinical Research Site

Cagliari, Italy/Cagliari 09047 - Italy

Status: Contact for availability

Clinical Research Site

Livorno, Italy/Livorno 57124 - Italy

Status: Contact for availability

Clinical Research Site

Napoli, italy/Napoli 80147 - Italy

Status: Contact for availability

Clinical Research Site

Padova, Italy/Padova 35128 - Italy

Status: Contact for availability

Clinical Research Site

Pavia, Italy/Pavia 27100 - Italy

Status: Contact for availability

Clinical Research Site

Messina, ME 98124 - Italy

Status: Contact for availability

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Glioblastoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships